Researchers have created an AI tool that uses CT imaging to predict the spread risk of oropharyngeal cancer, offering improved treatment stratification.
Key Details
- 1Developed and validated by Mass General Brigham and Dana-Farber Cancer Institute.
- 2AI tool predicts likelihood of lymph node extranodal extension (ENE) using CT scans.
- 3Tested on imaging data from 1,733 patients with oropharyngeal carcinoma.
- 4Integration of AI assessment improved risk stratification for survival and cancer spread.
- 5Could guide both escalation and de-escalation of treatment strategies.
- 6Published in Journal of Clinical Oncology (DOI: 10.1200/JCO-24-02679).
Why It Matters
This tool offers a noninvasive approach for more accurate prognosis and tailored therapies in head and neck cancer, potentially reducing unnecessary interventions and improving outcomes. It demonstrates a significant advance in leveraging imaging AI for complex cancer management decisions.
Source
EurekAlert
Related News
•EurekAlert
USC Receives $3M Gift for Alzheimer's Research Involving Imaging and AI
A $3 million donation to USC will accelerate Alzheimer's research, including imaging modality development and AI-based molecular analysis.
•EurekAlert
AI Pathology Analysis Predicts Immunotherapy Response in Rare Tumors
AI-based analysis of tumor pathology slides can predict immunotherapy outcomes in rare cancers, according to a recent MD Anderson study.
•EurekAlert
Review Highlights AI's Impact on Breast Cancer Imaging and Recurrence Prediction
A major review details how AI enhances early detection and recurrence prediction in breast cancer imaging.